Respiratory syncytial virus bronchiolitis: Supportive care and therapies designed to overcome airway obstruction

Pediatric Infectious Disease Journal

Volumn 22, Issue SUPPL. 2, 2003, Pages

  Panitch, Howard B ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Bronchodilators; Corticosteroids; End tidal rapid thoracoabdominal compression technique; Exogenous surfactant; Heliox; Mechanical ventilation; Pulse oximetry; Raised volume rapid thoracoabdominal compression

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; HELIOX; RIBAVIRIN; SALBUTAMOL; SURFACTANT; THEOPHYLLINE;

ADJUVANT THERAPY; AIRWAY OBSTRUCTION; ARTIFICIAL VENTILATION; BRONCHIOLITIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; DRUG ACTIVITY; DRUG MECHANISM; FLUID THERAPY; HELIUM OXYGEN BREATHING; HUMAN; META ANALYSIS; OXYGEN THERAPY; PRIORITY JOURNAL; PULSE OXIMETRY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK BENEFIT ANALYSIS; SYMPTOM; VIRUS REPLICATION;

AIRWAY OBSTRUCTION; ANTIVIRAL AGENTS; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FLUID THERAPY; HUMANS; INFANT; INFANT, NEWBORN; OXYGEN INHALATION THERAPY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RIBAVIRIN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VIRUS REPLICATION;

EID: 0037328840     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200302001-00012     Document Type: Conference Paper

References (33)

1. Garzon L, Wiles L. Management of respiratory syncytial virus with lower respiratory tract infection in infants and children. AACN Clin Issues 2002;13:421-30.
2. DeVincenzo J. Prevention and treatment of respiratory syncytial virus infection. In: Aronoff SC, ed. Advances in pediatric infectious diseases. Philadelphia: Mosby-Year Book, 1998.
3. Panitch HB, Callahan CW Jr, Schidlow DV. Bronchiolitis in children. Clin Chest Med 1993;14:715-31.
4. Garrison MM, Christakis DA, Harvey E, et al. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics 2000;105:e44. URL: http://www.pediatrics.org/cgi/content/full/105/4/e44.
5. Khoshoo V, Edell D. Previously healthy infants may have increased risk of aspiration during respiratory syncytial viral bronchiolitis. Pediatrics 1999;104:1389-90.
6. Quittell LM, Wolfson MR, Schidlow DV. The effectiveness of chest physical therapy (CPT) in infants with bronchiolitis. Am Rev Respir Dis 1988;137:406A.
7. Springer C, Bar-Yishay E, Uwayyed K, et al. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol 1990;9:181-5.
8. Callen Blecua M, Aizpurua Galdeano P, Ozcoidi Erro I, et al. Inhaled corticosteroids and wheezing post-bronchiolitis (in Spanish). An Esp Pediatr 2000;52:351-5.
9. Nahata MC, Johnson JA, Powell DA. Management of bronchiolitis. Clin Pharm 1985;4:297-303.
10. Brooks LJ, Cropp GJ. Theophylline therapy in bronchiolitis: a retrospective study. Am J Dis Child 1981;135:934-6.
11. Greenough A, Elias-Jones A, Pool J, et al. The therapeutic actions of theophylline in preterm ventilated infants. Early Hum Dev 1985;12:15-22.
12. Buckingham SC, Jafri HS, Bush AJ, et al. A randomized, double-blind, placebo -controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome. J Infect Dis 2002;185:1222-8.
13. Berger I, Argaman Z, Schwartz SB, et al. Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up. Pediatr Pulmonol 1998;26:162-6.
14. Leer JA, Green JL, Heimlich EM, et al. Corticosteroid treatment in bronchiolitis: a controlled, collaborative study in 297 infants and children. Am J Dis Child 1969;117:495-503.
15. Roosevelt G, Sheehan K, Grupp-Phelan J, et al. Dexamethasone in bronchiolitis: a randomized controlled trial. Lancet 1996;348:292-5.
16. Connolly JH, Field CMB, Glasgow JFT, et al. A double-blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus. Acta Paediatr Scand 1969;58:116-20.
17. Van Woensel JB, Wolfs TF, van Aalderen VM, et al. Randomised double-blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997;52:634-7.
18. Schuh S, Coates AL, Binnie R, et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr 2002;140:27-32.
19. Kellner JD, Ohlsson A, Gadomski AM, et al. Efficacy of bronchodilator therapy in bronchiolitis: a meta-analysis. Arch Pediatr Adolesc Med 1996;150:1166-72.
20. Modl M, Eber E, Weinhandl E, et al. Assessment of bronchodilator responsiveness in infants with bronchiolitis: a comparison of the tidal and the raised volume rapid thoracoabdominal compression technique. Am J Respir Crit Care Med 2000;161:763-8.
21. Wohl ME, Chernick V. State of the art: bronchiolitis. Am Rev Respir Dis 1978;118:759-81.
22. Sanchez I, De Koster J, Powell RE, et al. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr 1993;122:145-51.
23. Bertrand P, Aranibar H, Castro E, et al. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatr Pulmonol 2001;31:284-8.
24. Numa AH, Williams GD, Dakin CJ. The effect of nebulized epinephrine on respiratory mechanics and gas exchange in bronchiolitis. Am J Respir Crit Care Med 2001;164:86-91.
25. Schindler M. Do bronchodilators have an effect on bronchiolitis? Crit Care 2002;6:111-2.
26. Tal A, Bavilski C, Yohai D, et al. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983;71:13-8.
27. Tibby SM, Hatherill M, Wright SM, et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000;162:1251-6.
28. Hogg, J. Age as a factor in the distribution of lower-airway conductance and in the pathologic anatomy of obstructive lung disease. N Engl J Med 1970;282:1283-7.
29. Manthous CA, Hall JB, Caputo MA, et al. Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma. Am J Respir Crit Care Med 1995;151:310-14.
30. Wolfson MR, Bhutani VK, Shaffer TH, Bowen FW Jr. Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. J Pediatr 1984;104:752-7.
31. Hollman G, Shen G, Zeng L, et al. Helium-oxygen improves clinical asthma scores in children with acute bronchiolitis. Crit Care Med 1998;26:1731-6.
32. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Heliox therapy in infants with acute bronchiolitis. Pediatrics 2002;109:68-73.
33. Tobias JD. Heliox in children with airway obstruction. Pediatr Emerg Care 1997;13:29-32.